USCB (USCB) CEO de la Aguilera exercises options, sells 3,290 Class A shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
USCB Financial Holdings, Inc. President and CEO Luis de la Aguilera exercised stock options for 3,290 shares of Class A Voting Common Stock at $12.05 per share and sold 3,290 shares in open‑market transactions at weighted prices of $18.06 and $18.05. Following these transactions, he directly holds 242,945 Class A shares. The sales were executed in multiple trades within price ranges of $18.02–$18.19 and $18.00–$18.17.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 3,290 shares ($59,409)
Net Sell
6 txns
Insider
DE LA AGUILERA LUIS
Role
President and CEO
Sold
3,290 shs ($59K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 2,485 | $0.00 | -- |
| Exercise | Class A Voting Common Stock | 2,485 | $12.05 | $30K |
| Sale | Class A Voting Common Stock | 2,485 | $18.06 | $45K |
| Exercise | Stock Option (Right to Buy) | 805 | $0.00 | -- |
| Exercise | Class A Voting Common Stock | 805 | $12.05 | $10K |
| Sale | Class A Voting Common Stock | 805 | $18.05 | $15K |
Holdings After Transaction:
Stock Option (Right to Buy) — 108,601 shares (Direct, null);
Class A Voting Common Stock — 245,430 shares (Direct, null)
Footnotes (1)
- Includes the grant of 27,632 shares of restricted stock which vest at a rate of one-third per year commencing on January 27, 2027, 17,102 shares of restricted stock from a grant of 25,653 shares which commenced vesting at a rate of one-third per year on January 21, 2026, 4,045 shares of restricted stock from a grant of 12,136 shares which commenced vesting at a rate of one-third per year on January 22, 2025, and 41,666 shares of restricted stock from a grant of 125,000 shares which commenced vesting at a rate of one-third per year on December 31, 2024. The price reported in column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $18.02 to $18.19, inclusive. The reporting person undertakes to provide to USCB, or any security holder of USCB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.17, inclusive. The reporting person undertakes to provide to USCB, or any security holder of USCB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock options vested at the rate of one-third per year commencing on September 27, 2022.
Key Figures
Shares sold: 3,290 shares
Sale price (2,485 shares): $18.06 per share
Sale price (805 shares): $18.05 per share
+5 more
8 metrics
Shares sold
3,290 shares
Open‑market sales of Class A Voting Common Stock
Sale price (2,485 shares)
$18.06 per share
Weighted average sale price on 2,485 shares
Sale price (805 shares)
$18.05 per share
Weighted average sale price on 805 shares
Options exercised
3,290 shares
Stock options exercised into common shares
Exercise price
$12.05 per share
Conversion price for exercised stock options
Shares held after
242,945 shares
Direct Class A Voting Common Stock holdings post‑transactions
Restricted stock grant
27,632 shares
Restricted stock vesting one‑third per year from January 27, 2027
Option expiration
September 27, 2031
Expiration date for the exercised stock option grant
Key Terms
Class A Voting Common Stock, Stock Option (Right to Buy), restricted stock, weighted price, +1 more
5 terms
Class A Voting Common Stock financial
"security_title: "Class A Voting Common Stock""
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
restricted stock financial
"Includes the grant of 27,632 shares of restricted stock which vest at a rate of one-third per year"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
weighted price financial
"The price reported in column 4 is a weighted price."
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What insider transactions did USCB (USCB) CEO Luis de la Aguilera report?
Luis de la Aguilera reported exercising stock options and selling common shares. He exercised options for 3,290 shares at $12.05 each and sold 3,290 Class A Voting Common shares in open‑market trades at weighted average prices of $18.06 and $18.05.
What stock option activity did the USCB (USCB) CEO report on this Form 4?
He exercised stock options covering 3,290 underlying common shares at a conversion price of $12.05 per share. These options, described as a Stock Option (Right to Buy), vest in thirds beginning September 27, 2022, and were associated with grants expiring September 27, 2031.
What restricted stock awards are included in the USCB (USCB) CEO’s holdings?
His holdings include several restricted stock grants, such as 27,632 shares vesting one‑third per year starting January 27, 2027, plus portions of earlier grants of 25,653, 12,136, and 125,000 shares that began vesting in thirds on January 21, 2026, January 22, 2025, and December 31, 2024.